Matthew T. Plavan, Chief Executive Officer at Arcadia Biosciences, Inc. (RKDA), bought 700 shares at $1.72 ($1K) on 2020-02-03, disclosed to the SEC on 2020-02-04.
Open-market purchase of $1k RKDA by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| ORGN | SELL | 2025-11-04 | $83K | — | Filing → |
| ORGN | SELL | 2025-03-07 | $8K | — | Filing → |
| ORGN | SELL | 2024-12-31 | $25K | — | Filing → |